Destination
USA, Puerto Rico and US Virgin Islands
- Latest exports
- $51.2M
- Market share
- 13.3%
- Growth
- +48.5%
- Access
- 0% tariff
- Signal
- Accelerating
T3 · Product exporter position
India exports of Glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001 (HS 300190)
See where India stands in glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001: export scale, destination breadth, market position, growth, and reported trade history.
Latest exports
$81.0MLatest observed lane totalDestination markets
134Reported active marketsThree-year growth
+14.5%Annualized changeDestination HHI
4,156Destination concentrationWeighted share
25%Reported market positionExporter evidence
How strong is India in Glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001?
Reported exporter totals and calculated indicators for HS 300190. Values retain their observed coverage period.
Exporter scale
Latest exports$81.0M
Current 2024 exports$68.8M
Three-year average$61.4M
Historical peak$137.9M
Market position
Active destinations134
Destination HHI4,156
Weighted share25%
Share change+8.2 pp
Competitiveness
Three-year growth+14.5%
Volatility1.8
Maximum drawdown94.3%
TrendRapid growth
| Measure | Value | What it describes |
|---|---|---|
| Exporter | India | Country represented by this profile |
| Latest observed exports | $81.0M | Sum of latest observed destination-lane values |
| Current 2024 exports | $68.8M | Common-year comparison where reported |
| Three-year growth | +14.5% | Annualized change in exporter totals |
| Five-year growth | +39.8% | Annualized change in exporter totals |
| Leading destination | USA | Destination with the largest observed export value |
| Leading destination share | 63.2% | Share of observed exporter totals |
| Destination concentration | 4,156 | HHI across destination markets |
| Weighted share change | +8.2 pp | Value-weighted latest change in market share |
| Limited-history lanes | 13.8% | Share of lanes with shorter history |
Destination markets
Where does India sell glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001?
Leading destination observations ranked by reported export value, with market position and access context.
| Destination | Latest exports | Market share | Growth | Access | Signal |
|---|---|---|---|---|---|
| USA, Puerto Rico and US Virgin Islands | $51.2M | 13.3% | +48.5% | 0% tariff | Accelerating |
Price intelligence
How does India's price position vary?
Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.
Highest reported price
Japan: $83.0M / ton.
Lowest reported price
Mali: $1.4K / ton.
Median price
$146.4K / ton across reported markets.
Export trend
Reported export history
Annual observations for India and HS 300190 where available.
| Year | Exports | Year-on-year change | Active destinations |
|---|---|---|---|
| 2010 | $11.1M | -29.7% | 103 |
| 2011 | $12.6M | +13.2% | 74 |
| 2012 | $21.9M | +74.6% | 73 |
| 2013 | $23.0M | +5.1% | 70 |
| 2014 | $11.5M | -50.2% | 60 |
| 2015 | $13.5M | +17.3% | 63 |
| 2016 | $12.8M | -4.7% | 63 |
| 2017 | $10.8M | -15.6% | 77 |
| 2018 | $14.3M | +32.2% | 91 |
| 2019 | $12.9M | -9.9% | 98 |
| 2020 | $25.7M | +99% | 107 |
| 2021 | $45.8M | +78.5% | 105 |
| 2022 | $56.8M | +23.9% | 129 |
| 2023 | $58.5M | +3.1% | 129 |
| 2024 | $68.8M | +17.5% | 134 |
Exporter context
India economy and trade network
The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300190.
India has reported exports of $434.2B and a trade balance of -$221.5B in 2024.
Available structural indicators include 24.9% trade openness, 35.7% investment, and 270 active trade partners.
Reported values
Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.
Calculated indicators
Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.
Coverage
Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.
Frequently asked questions
Questions about India glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001 exports
Quick answers based on the figures and coverage shown on this page.
How strong is this exporter?+
Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.
Which markets are most important?+
The destination table ranks reported markets by the latest observed export value.
Does the price section show quotes?+
No. It summarizes reported trade value and quantity observations converted to unit values.
What should be checked next?+
Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.